SCHEMBL3648334

SCHEMBL3648334

Fc1ccccc1-c1ccc(S)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ PTPRC P08575 1/20 0.47
▸ PTPN1 P18031 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.43
▸ ACMSD Q8TDX5 1/20 0.42
▸ BACE1 P56817 1/20 0.41
▸ TRPA1 O75762 1/20 0.41
▸ PDK2 Q15119 1/20 0.40
▸ GRIA4 P48058 4/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ PPARG P37231 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ APEX1 P27695 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ DHODH Q02127 1/20 0.38
▸ TNKS O95271 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19502452 0.98 ALDH1A1 (0.46) ALDH1A1MAPTL3MBTL1PTPRCPTPN1
SCHEMBL26046508 0.90 PTPRC (0.53) ALDH1A1MAPTL3MBTL1PTPRCPTPN1
SCHEMBL12856701 0.87 PTPRC (0.56) ALDH1A1MAPTL3MBTL1PTPRCPTPN1
SCHEMBL23047589 0.82 WDR5 (0.42) ALDH1A1MAPTL3MBTL1PTPRCPTPN1
SCHEMBL30170547 0.82 ABL1 (0.42) ALDH1A1BACE1
SCHEMBL5698461 0.81 PTGS2 (0.52) ALDH1A1MAPTPDK2MAP4K4NPC1
SCHEMBL533630 0.80 PTGS2 (0.50) ALDH1A1MAPTL3MBTL1PTPRCPTPN1
SCHEMBL2140802 0.80 ALDH1A1 (0.50) ALDH1A1MAPTL3MBTL1PTPRCPTPN1
SCHEMBL30543293 0.80 ALDH1A1 (0.50) ALDH1A1MAPTL3MBTL1PTPRCPTPN1
SCHEMBL201614 0.79 L3MBTL1 (0.50) ALDH1A1MAPTL3MBTL1PTPRCPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022008475-A1 INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER UNIVERSITE CLAUDE BERNARD LYON 1 (FR) 2022-01-13 — — WO disclosed
EP-2190822-A2 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2010-06-02 — — EP disclosed
WO-2009041705-A9 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS TAKEDA PHARMACEUTICAL (JP) 2009-08-13 — — WO disclosed
WO-2009041705-A2 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-04-02 — — WO disclosed
US-4629733-A CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1986-12-16 — — US disclosed
Send feedback